EFFECT ·Filed Mar 3, 2026

PRTA

PROTHENA CORP PUBLIC LTD CO
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago SEC9999999995-26-000697
IPO/offering going effective
Actionable Insight • Neutral

Monitor for a subsequent pricing or prospectus supplement filing that would disclose offering size, price, and timing. The effectiveness creates potential for near-term share issuance, which could lead to dilution if equity is sold.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d
PRTA ▲ +7.16% at T+60d
NEUTRAL call ✓ call won +7.16% · α vs SPY -3.16% · entry $9.36 → $10.03
Entry anchored
Mar 2, 03:59 PM ET
via exchange tick
T+1d
+5.34%
call +5.34% · α +4.58%
$9.86
settled 7mo ago
T+5d
+4.38%
call +4.38% · α +4.86%
$9.77
settled 7mo ago
T+20d
+3.85%
call +3.85% · α +8.25%
$9.72
settled 6mo ago
T+60d
+7.16%
call +7.16% · α -3.16%
$10.03
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Analysis based on filing metadata only — document content was unavailable. This is an EFFECT filing, indicating that a previously filed registration statement (likely a shelf registration) has become effective, allowing Prothena to issue securities immediately. No financial details or offering terms are available in the provided documents.

Key Facts

  • EFFECT filing indicates a registration statement has become effective as of March 2, 2026
  • SEC File Number: 333-277290, suggesting this relates to a prior Form S-3 or F-3 registration
  • Company is based in Dublin, Ireland and operates in the life sciences sector
  • No offering size, pricing, or use of proceeds disclosed in available documents
  • Filing does not indicate whether this is an IPO, follow-on, or shelf takedown

Financial Impact

Not specified

dilutioncash

Risk Factors

  • Potential for unexpected equity issuance under the shelf registration, leading to dilution
  • Lack of transparency on offering terms increases uncertainty for shareholders

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000697
Document: 9999999995-26-000697-index.html9999999995-26-000697
Document: 9999999995-26-000697.txt9999999995-26-000697
10 reports for PRTA
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+60▲ +14.11%Jun 12, 2026
Filters
Rows
Reports for PRTA — sortable, filterable
TypeNow
Sep 3, 2026
28d ago
Insider Buy
NEUTRAL ★ 3/10
$9.82 $8.86▼ −9.78%▼ −8.57%$8.44 (−14.05%)
Aug 21, 2026
6w ago
Insider Buy
BULLISH ★ 4/10
$9.45 $9.33▼ −1.27%▼ −1.74%$8.44 (−10.69%)
Aug 10, 2026
7w ago
Insider Buy
BULLISH ★ 5/10
$9.12 $8.88▼ −2.63%▼ −2.58%$8.44 (−7.46%)
Jul 31, 2026
9w ago
Insider Cluster
NEUTRAL ★ 2/10
$8.12 $8.76▲ +7.88%▲ +4.37%$8.44 (+3.94%)
Jun 18, 2026
15w ago
Insider Buy
BULLISH ★ 5/10
$8.93 $9.27▲ +3.81%▲ +5.47%$8.44 (−5.49%)
Jun 12, 2026
15w ago
Insider Buy
BULLISH ★ 5/10
$8.15 $9.15▲ +12.27%▲ +13.65%$8.44 (+3.56%)
May 14, 2026
20w ago
3
NEUTRAL ★ 2/10
$9.76 $9.83▲ +0.72%▼ −0.25%$8.44 (−13.52%)
May 7, 2026
21w ago
8-K
BULLISH ★ 8/10
$10.73 $9.86▼ −8.11%▼ −9.57%$8.44 (−21.34%)
Mar 27, 2026
26w ago
DEFA14A
NEUTRAL ★ 3/10
$9.25 $10.36▲ +12.00%▲ +7.70%$8.44 (−8.76%)
Mar 3, 2026
30w ago
EFFECT
NEUTRAL ★ 3/10
$9.36 $9.77▲ +4.38%▲ +4.86%$8.44 (−9.83%)
Showing 10 of 10

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access